INVITRO ACTIVITY OF CEFOTAXIME AGAINST CLINICAL ISOLATES OF YERSINIA-ENTEROCOLITICA BIOTYPE-4, SEROTYPE-03

被引:5
作者
GAHRNHANSEN, B
SOGAARD, P
机构
关键词
D O I
10.1093/jac/26.4.599
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:599 / 600
页数:2
相关论文
共 9 条
[1]  
BISSETT ML, 1976, J CLIN MICROBIOL, V4, P137
[2]  
BOUZA E, 1980, AM J CLIN PATHOL, V74, P404
[3]   YERSINIA ENTEROCOLITICA SEPTICEMIA - CLINICAL AND MICROBIOLOGICAL ASPECTS [J].
FOBERG, U ;
FRYDEN, A ;
KIHLSTROM, E ;
PERSSON, K ;
WEILAND, O .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1986, 18 (04) :269-279
[4]   FATAL YERSINIA ENTEROCOLITICA SEPTICEMIA [J].
JOSEFSSON, K ;
LINDBERG, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1975, 7 (01) :76-77
[5]   YERSINIA-ENTEROCOLITICA - COMPARATIVE INVITRO ACTIVITIES OF 7 NEW BETA-LACTAM ANTIBIOTICS [J].
SCRIBNER, RK ;
MARKS, MI ;
WEBER, A ;
PAI, CH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (01) :140-141
[6]  
SIBONI K, 1968, ACTA PATHOL MIC SC, V74, P381
[7]  
SOGAARD P, 1983, ACTA PATH MICRO IM B, V91, P49
[8]  
SOGAARD P, 1985, ACTA PATHOLOGICA M B, V93, P265